Loading...
HSChapter 30
U.S. imports of miscellaneous medicaments (not in dosage form, nesoi) (HS 300390) totaled $96.8M in April 2026, traded with 34 countries.
Importers of Miscellaneous Medicaments (Not in Dosage Form, NESOI) paid $62K in duties in April 2026 — an effective duty rate of 9.9% on $624K in dutiable value, based on actual customs collections rather than the published tariff schedule. Miscellaneous Medicaments (Not in Dosage Form, NESOI) imports of $96.8M in April 2026 ran 22% above the year-to-date monthly average of $79.4M.
Last updated: April 2026 dataPortugal and Singapore lead US supply under this residual pharmaceutical heading, which captures antiviral, antifungal, antiprotozoal, and other anti-infective bulk preparations — as well as a broad NESOI category — that do not fit more specific headings and are not yet in retail dosage form. The US schedule subdivides the heading into five 10-digit lines (3003900120 through 3003900190) by therapeutic class, enabling more granular trade monitoring of critical drug categories such as antivirals and antifungals that have drawn supply-chain scrutiny since the COVID-19 pandemic. Ireland and China are also significant sources, underscoring the geographic concentration risk in global API supply chains. FDA establishment registration and cGMP compliance are mandatory for all entries.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
The granular subdivision allows US trade authorities to monitor import volumes of specific therapeutic classes independently — a priority that intensified after supply disruptions exposed concentration risks in critical drug categories. It also facilitates targeted enforcement actions or trade-remedy measures at the class level without affecting the entire heading.
A significant share of global API manufacturing for anti-infectives is concentrated in a small number of countries and facilities. Importers should assess single-source dependency, maintain visibility into sub-tier suppliers (including starting materials), and review FDA warning letters or import alerts for their foreign manufacturers, as an active import alert can halt an entire product line at the border.
| Country | Imports | Exports | Balance |
|---|---|---|---|
| PORTUGAL | $64.1M | $108K | -$64.0M |
| IRELAND | $2.5M | $33.6M | +$31.1M |
| NETHERLANDS | -- | $25.3M | +$25.3M |
| INDIA | $2.3M | $13.7M | +$11.4M |
| BELGIUM | $507K | $10.7M | +$10.2M |
Supplier Network
Get discovered by U.S. importers searching for HS 300390 — Miscellaneous Medicaments (Not in Dosage Form, NESOI). Be the first supplier listed.
Monthly import values over time
HS10 import codes under this HS6 parent. Source: U.S. Harmonized Tariff Schedule.
| Code | Description | Import Value | Effective Tariff % | Duty Collected |
|---|---|---|---|---|
| 3003900190 | MEDICAMENTS NOT MEASURED DOSES OR FOR RETAIL NESOI | $91.4M | 10.00% | $61K |
| 3003900140 | ANTIFUNGALS, NOT MEASURED DOSES OR FOR RETAIL | $2.9M | 7.50% | $938 |
| 3003900120 | ANTIVIRALS, NOT MEASURED DOSES OR FOR RETAIL | $1.3M | -- | -- |
| 3003900180 | ANTI-INFECTIVE MEDS NOT MEAS DOSES OR RETAIL NESOI | $1.2M | -- | -- |
| 3003900160 | ANTIPROTOZOALS, NOT MEAS DOSES OR FOR RETAIL | $0 | -- | -- |
MEDICAMENTS NOT MEASURED DOSES OR FOR RETAIL NESOI
ANTIFUNGALS, NOT MEASURED DOSES OR FOR RETAIL
ANTIVIRALS, NOT MEASURED DOSES OR FOR RETAIL
ANTI-INFECTIVE MEDS NOT MEAS DOSES OR RETAIL NESOI
ANTIPROTOZOALS, NOT MEAS DOSES OR FOR RETAIL
HS10 export codes under this HS6 parent. Source: U.S. Schedule B export classification.
| Code | Description | Export Value |
|---|---|---|
| 3003900190 | MEDICAMENTS NOT MEASURED DOSES OR FOR RETAIL NESOI | $107.8M |
| 3003900120 | ANTIVIRALS, NOT MEASURED DOSES OR FOR RETAIL | $428K |
| 3003900180 | ANTI-INFECTIVE MEDS NOT MEAS DOSES OR RETAIL NESOI | $52K |
| 3003900140 | ANTIFUNGALS, NOT MEASURED DOSES OR FOR RETAIL | $0 |
| 3003900160 | ANTIPROTOZOALS, NOT MEAS DOSES OR FOR RETAIL | $0 |
MEDICAMENTS NOT MEASURED DOSES OR FOR RETAIL NESOI
577.3K kg
ANTIVIRALS, NOT MEASURED DOSES OR FOR RETAIL
5.7K kg
ANTI-INFECTIVE MEDS NOT MEAS DOSES OR RETAIL NESOI
19.5K kg
ANTIFUNGALS, NOT MEASURED DOSES OR FOR RETAIL
ANTIPROTOZOALS, NOT MEAS DOSES OR FOR RETAIL
MEDICAMENTS NESOI, MEASURED DOSES, RETAIL PK NESOI
HS 300490
IMMUNOLOGICAL PRODUCTS, IN MEASURED DOESE/RTL SALE
HS 300215
VACCINES FOR HUMAN MEDICINE
HS 300241
HORMONES ETC. (NO ANTIBIOTICS CONTAINED) DOSAGE FM
HS 300439
ANTISERA AND OTHER BLOOD FRACTIONS
HS 300212
IMMUNOLOGICAL PRODUCTS, MIXED, NOT IN MSRED DOSES
HS 300214
| State | Imports | Exports | Balance |
|---|---|---|---|
| Indiana | $62.3M | $98K | -$62.2M |
| Massachusetts | $3.9M | $53.7M | +$49.8M |
| California | $1.4M | $25.5M | +$24.2M |
| Port | Imports | Exports | Balance |
|---|---|---|---|
| PHILADELPHIA INTERNATIONAL AIRPORT, PA | $63.5M | -- | -$63.5M |
| NEW ORLEANS, LA | $87K | $31.5M | +$31.4M |
| SAN FRANCISCO INTERNATIONAL AIRPORT, CA | $101K | $25.6M | +$25.5M |